Pfizer (PFE)

Operating Income Growth

31.64%

Quarterly · Period ending:

PFE logo

PFE Operating Income Growth

Year-over-year change vs the same period a year earlier

Latest reported31.64%
PFE Quarterly Operating Income YoY % (14.84% → 31.64%)
High-resolution chart · PNG

PFE operating income growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Pfizer Operating Income Growth — Quarterly
Period endingOperating Income Growth
55.129%
92.2759%
75.8806%
124.9754%
55.6489%
25.4325%
64.0704%
3.4588%
10.0719%
20.7941%
-4.6707%
11.0734%
39.5983%
2.9032%
4.2447%
5.988%
21.4286%
14.9567%
18.878%
20.7695%
7.0097%
28.2295%
33.9829%
36.3977%
35.0453%
11.565%
245.515%
13.0968%
-28.2644%
15.9287%
-196.7525%
11.2159%
101.7857%
19.3249%
36.9632%
7.9272%
11.2733%
9.6861%
23.8367%
13.6682%
17.8213%
22.0367%
106.5622%
-77.1637%
-83.9334%
-78.737%
-6.788%
4.0205%
-2.5217%
10.6634%
-11.151%
6.549%
8.9072%
15.9253%
-14.8891%
11.5897%
9.7683%
8.4779%
-12.7864%
14.84%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.